After an extensive review of startups with transformative technologies in the Life Sciences market, BioSpace today ranked SureClinical on its annual list of ‘Top 30 Life Science Startups To Watch In The U.S.’
After an extensive review of startups with transformative technologies in the Life Sciences market, BioSpace today ranked SureClinical on its annual list of ‘Top 30 Life Science Startups To Watch In The U.S.’
The recognition from BioSpace is an additional validation point supporting the rapid movement of life science companies from legacy software applications to cloud and mobile solutions. At SureClinical we continue to see explosive market demand by life science companies who want to move to the cloud. These companies seek solutions to the problems of maintenance, support, expense and inconvenience of legacy software applications, and they aren’t fooled by legacy software solutions that are simply hosted in a data center and called ‘cloud’. True cloud solutions enable companies to move from islands of automation to a true community computing approach, embracing interoperability and web standards. SureClinical is the first eTMF cloud software vendor to adopt the OASIS eTMF Standard, enabling higher data quality, consistency and interoperability with existing systems.